LATEST TWEETS - CURATED BY HASH FINANCE

$SNY Hey, at least this got me my PS4 before this happened. Got out at a good time. https://t.co/2Ub59Pw0vw
@TomHolland1996 @domholland Alright brother man … if $SNY and $DIS can't agree on MCU, I bet you threatening to lea… https://t.co/eP3aZRCe5F
Wayne (wyv_123) 1 day ago
@stefanomjr I was wondering about that or partnership. It would make sense with beta thal results and their ERT bus… https://t.co/1BhXqmqbKf
@wyv_123 Manufacturing in France point to a $SNY buyout? Sanofi terminated partnership w/ $LXRX - getting ready for… https://t.co/KhEKfJBeOz
Wayne (wyv_123) 2 days ago
$SGMO wonder if there is any connection to Sanamo’s last minute European detour from ISTH in Australia, Sandy menti… https://t.co/GvP8Lco9sg
POTUS (Lynx_lynx7) 2 days ago
$SGMO - SB-525 ( $PFE )follow up patient data in 4Q 19 - ST-920 First patient enrollment expected 4Q 19 - TX-200 P… https://t.co/azRO0HjSTf
$SNY 50 MA is key factor here break or help
Celgene and the scientist who championed #fedratinib's rise from Sanofi's R&D graveyard win FDA OK https://t.co/Fqn3lul8Wo $CELG $SNY
Sanofi $SNY Upgraded to “Buy” at UBS Group https://t.co/EMk9w3t0eZ
Sanofi $SNY Upgraded at UBS Group https://t.co/UENbsge2Ws
Sanofi $SNY Upgraded at UBS Group https://t.co/HaHZyWMkUK
Here's what I wrote about @PrezCamacho in 2017. Pretty amazing (and fast!) turnaround story. Raises some questions… https://t.co/WmXro0hoNf
FDA approval of Celgene's Inrebic sets up a potential blockbuster launch for BMS and gives #myelofibrosis patients… https://t.co/bMY3zB0NXs
$SNY - Sanofi prevails in appeal of Mozobil patents https://t.co/69lnCNSPTz
$SNY Phase 3 Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome…NCT03… https://t.co/vtHd2okfcV
Sanofi $SNY Technical Update https://t.co/67qWnsISZ2 & Trading Plans Too. https://t.co/WeI6TM8Set
Sanofi $SNY Technical Update https://t.co/hrsC2guV58 Trading Plans Too.
Sanofi $SNY Upgraded to “Buy” at UBS Group https://t.co/YNf3TaE6q6
Sanofi $SNY Upgraded to “Buy” at UBS Group https://t.co/jT5MorKgTj
Sanofi Upgrade by UBS (Ranked 3rd) to Buy $SNY #SNY https://t.co/fKCnLZVwQb
Sanofi $SNY Upgraded to Buy by UBS Group https://t.co/04YW0Y4gCs #stocks
$SNY: Should Value Investors Consider Sanofi (SNY) Stock Now?: https://t.co/yAlWklt1WF
Sanofi SA $SNY Given Consensus Rating of “Hold” by Brokerages https://t.co/SsVCDJHPyi #stocks
Another CD123 targeting agent bite-ing the dust, this time SAR440234 CD3xCD123 bispec? Recruitment status set to Su… https://t.co/ntEObIHklp